1-8 of 8
Mary Slavcev
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Results of a Time and Motion Survey Regarding Subcutaneous Versus Intravenous Administration of Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

Mary Slavcev, Allison Spinelli, MSc, Elisabeth Absalon, Tara Masterson, MSc, Chris Heuck, MD, Annette Lam, MSc, Erwin De Cock, MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-139995
Published: 2020
Journal Articles

A Network Meta-Analysis (NMA) to Evaluate Comparative Effectiveness of Frontline Treatments for Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Transplant-Ineligible (TIE)

Thierry Facon, MD, Jesús San-Miguel, Saad Z. Usmani, MD, Meletios A. Dimopoulos, MD, Shaji K. Kumar, MD, Maria-Victoria Mateos, Michele Cavo, Bart Heeg, PhD, Sophie Van Beekhuizen, MSc, Marta Pisini, MBA, Sandhya Nair, Annette Lam, BSc, MSc, Mary Slavcev, Jianming He, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2144.
https://doi.org/10.1182/blood-2019-123561
Published: 2019
Journal Articles

Characterization of Frontline Treatment Patterns and Attrition Rates According to Subsequent Lines of Therapy in Non-Transplant Patients with Newly Diagnosed Multiple Myeloma

Rafael Fonseca, MD, Saad Z. Usmani, MD, Maneesha Mehra, Mary Slavcev, Jon Ukropec, PhD, Annette Lam, Ravi Potluri
Journal: Blood
Blood (2018) 132 (Supplement 1): 3291.
https://doi.org/10.1182/blood-2018-99-113125
Published: 2018
Journal Articles

A Matching-Adjusted Indirect Treatment Comparison of Daratumumab-Bortezomib-Melphalan-Prednisone Versus Lenalidomide-Dexamethasone Continuous, Lenalidomide-Dexamethasone 18 Months, and Melphalan-Prednisone-Thalidomide

Meletios A Dimopoulos, MD, Michele Cavo, MD, Maria-Victoria Mateos, MD PhD, Thierry Facon, Bart Heeg, PhD, Sophie van Beekhuizen, Sandhya Nair, Marta Pisini, MBA, Annette Lam, Mary Slavcev
Journal: Blood
Blood (2018) 132 (Supplement 1): 3551.
https://doi.org/10.1182/blood-2018-99-113517
Published: 2018
Journal Articles

Evaluation and Comparison of Characteristics and Outcomes Among Frontline Multiple Myeloma (FLMM) Patients with and without Stem Cell Transplant Treatment

Ajai Chari, MD, Maneesha Mehra, Mary Slavcev, Annette Lam, Ravi Potluri, Jonathan L Kaufman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4738.
https://doi.org/10.1182/blood-2018-99-113176
Published: 2018
Journal Articles

Treatment Regimens for Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation: A Systematic Literature Review and Network Meta-Analysis

Jesus F San-Miguel, MD PhD, Thierry Facon, Meletios A Dimopoulos, MD, Maria-Victoria Mateos, MD PhD, Michele Cavo, MD, Bart Heeg, PhD, Sophie van Beekhuizen, Marta Pisini, MBA, Sandhya Nair, Annette Lam, Mary Slavcev
Journal: Blood
Blood (2018) 132 (Supplement 1): 4741.
https://doi.org/10.1182/blood-2018-99-113668
Published: 2018
Journal Articles

Evaluation of Efficacy Outcomes Among Relapsed/Refractory Multiple Myeloma Treated Patients in a Real-World Setting

Ajay Nooka, MDMPH, Peter M. Voorhees, MD, Shaji K Kumar, MD, Maneesha Mehra, Annette Lam, Mary Slavcev, Jon Ukropec, Ravi Potluri, Anandaroop Dasgupta
Journal: Blood
Blood (2017) 130 (Supplement 1): 3093.
https://doi.org/10.1182/blood.V130.Suppl_1.3093.3093
Published: 2017
Journal Articles

Comparison of Overall Survival Associated with Lenalidomide+Dexamethasone and Bortezomib+Dexamethasone Among Relapsed/Refractory Multiple Myeloma Patients: A Matched Analysis of Real World and Clinical Trial Populations

Ajay Nooka, MDMPH, Peter M. Voorhees, MD, Shaji K Kumar, MD, Maneesha Mehra, Annette Lam, Mary Slavcev, Ravi Potluri, Anandaroop Dasgupta
Journal: Blood
Blood (2017) 130 (Supplement 1): 3094.
https://doi.org/10.1182/blood.V130.Suppl_1.3094.3094
Published: 2017